Loading clinical trials...

COMPLETEDNA

Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention

NCT04522245•Noom Inc.

Summary

The aim of this study is to compare brain changes in individuals with overweight or obesity enrolled in either the Noom Healthy Weight program or a matched control. The study objectives (primary and secondary) are to measure brain change reported as ERP and EEG data over a 16-week timeframe. Additionally, we will explore changes in the default mode network (resting-state asymmetry in EEG measurements), changes in executive functioning, quality of life, mood, and salivary markers as they relate to EEG data.

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Each subject must be able to understand and provide informed consent
•Between the ages 18-60 years
•Self-report of good health
•Overweight or obesity (BMI ≥ 25)
•Able to meet our criteria of adherence to the program
•Able to attend in-person visit in Long Island, NY

Exclusion Criteria

•Inability or unwillingness to give written informed consent or comply with the study
•Visual impairment that cannot be corrected with glasses or contact lenses
•Any indication of drug, alcohol or medicine abuse.
•Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
•Presence of a brain injury, psychiatric disorders, seizure disorders, and other neurological conditions
•Reported eating disorder
•Currently pregnant or 6 months postpartum
•Planning to become pregnant within the next 5 months

Locations (1)

Focus Feedback

Commack, New York, United States

Key Dates

Start Date

October 1, 2020

Primary Completion Date

March 15, 2021

Completion Date

July 15, 2021

Last Updated

July 20, 2021

Enrollment

ACTUAL participants

Conditions

ObesityBehavior, HealthWeight Loss

Interventions

Noom Healthy Weight; mobile behavior change program for weight loss.

BEHAVIORAL

Matched Control

OTHER

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT01143454

Metabolic DiseaseObesity+4 more

View study

RECRUITINGNA

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

NCT07472881

MenopausePerimenopause+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention

Inclusion Criteria

Exclusion Criteria

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Protein Supplementation Intervention on Body Weight

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss